Pleural Empyema: Surgery vs. Drainage

We are studying whether surgery is more effective than drainage for treating pleural empyema. This trial will help us understand the best approach for patients with this condition.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Aldurazyme
Aldurazyme treats a rare inherited disorder by replacing a missing enzyme so the body can break down certain sugars.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Alteplase
Alteplase is a substance that dissolves blood clots to restore blood flow in emergencies like stroke, heart attack, or pulmonary embolism.
Dornase Alfa
Dornase alfa is a substance that thins and clears thick lung mucus by breaking down DNA, helping people with cystic fibrosis breathe easier.
Laronidase
Laronidase is a substance that replaces a missing enzyme to help remove harmful sugar buildup in people with mucopolysaccharidosis type I.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Aalborg University Hospital
Lungemedicinsk
Aalborg, Denmark
Rigshospitalet
Lungemedicinsk
Copenhagen, Denmark
Odense University Hospital
J
Odense, Denmark
Sponsor: Odense University Hospital
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.